Searchable abstracts of presentations at key conferences on calcified tissues

ba0007is8 | (1) | ICCBH2019

Vitamin D in pregnancy and offspring immunology

Hawrylowicz Catherine , Hornsby Eve , Cheadle Charlotte , Pfeffer Paul , Laranjo Nancy , Cruikshank William , Tuzova Marina , Litonjua Augusto A , Weiss Scott T , Carey Vincent J , O'Connor George

Vitamin D deficiency in pregnancy is common, and is linked to increased risk of adverse outcomes including preterm birth, preeclampsia, infection, gestational diabetes and asthma. Vitamin D possesses well-recognized immunomodulatory functions, and programming of the immune system during foetal development can influence asthma-related risk factors and health outcomes in later life. We hypothesized that influencing vitamin D status during pregnancy would impact the immune profil...

ba0003pp146 | Cell biology: osteoblasts and bone formation | ECTS2014

Strontium ranelate increases osteoblast cell proliferation and differentiation and the formation of bone-like mineralized matrix on different titanium substrates

Querido William , Farina Marcos , Anselme Karine

The integration of biomaterials into the calcified bone tissue is essential for the clinical success of bone implants. A particular strategy to improve such integration is the use of specific molecules to increase osteoblast cell adhesion, proliferation, and/or differentiation on the surface of the implants, aiming to enhance the interaction of cells with biomaterials. The goal of this study was to better understand the potential of the anti-osteoporotic drug strontium ranelat...

ba0005p82 | Bone Matrix | ECTS2016

CRISPR/Cas9-mediated IFITM5 gene editing demonstrates that BRIL (Ser40Leu) substitution suppresses PEDF-mediated activation of PPARγ

Kang Heeseog , Marini Joan

Osteogenesis imperfecta (OI) type VI is caused by recessive null mutations in SERPINF1, encoding pigment epithelium-derived factor (PEDF), an anti-angiogenic secretory glycoprotein. Dominant mutations in IFITM5, encoding BRIL (Bone Restricted Ifitm-Like), a transmembrane protein upregulated in osteoblasts during mineralization, cause either type V OI (c.-14C>T, addition of 5 amino acids on BRIL) or atypical type VI OI (...

ba0005p350 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Bone mineral density in women with Parkinson’s disease

Povoroznyuk Vladyslav , Bystrytska Maryna , Karaban' Irina , Karasevych Nina

Aim: The aim of the research is to define the bone mineral density in patients, with Parkinson’s disease.Methods: We examined 12 women with Parkinson’s disease and 12 healthy women of appropriate age (average age: −63.6±6.25 vs 62.2±6.83 years, P=0.5). The duration of Parkinson’s disease was at list 5 years. All patients reseived levodopa.Results: BMD of women with Parkinson’s disease wa...

ba0001niw3 | (1) | ECTS2013

Getting started as a post-doc

Rauner Martina

The first step to getting started as a post-doc is finding an appealing post-doc position. Be proactive and begin the search and application process early. One of the most critical aspects to think about is the research area. It should be something that excites you and something where you can imagine to work in for the next couple of years. Once you have decided on a research area, you can start thinking about choosing an adviser. The adviser has great power to help build a ca...

ba0001pp113 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Lower bone turnover in obesity: is there a link to energy metabolism?

Viljakainen Heli , Ivaska Kaisa K , Lipsanen-Nyman Marita , Saukkonen Tero , Andersson Sture , Laitinen Kalevi , Makitie Outi

Background: Observations in rodents suggest that osteocalcin (OC) participates in glucose metabolism. Data from human studies are inconclusive and it remains unclear whether OC is simply a marker of bone turnover (BTM) or if it also mediates interactions between the skeleton and glucose homeostasis. This study determined the responses of BTMs, including OC, to oral glucose tolerance test (OGTT) in obese and normal-weight subjects.Materials and methods: P...

ba0003pp145 | Cell biology: osteoblasts and bone formation | ECTS2014

Effects of strontium ranelate on the bone-like mineralized matrix produced in osteoblast cell cultures

Querido William , Campos Andrea , Ferreira Erlon Martins , Gil Rosane San , Rossi Alexandre , Farina Marcos

Strontium ranelate is a promising drug used in the treatment of osteoporosis. This drug has a unique dual effect on bone turnover, simultaneously increasing bone formation by osteoblasts (anabolic effect) and decreasing bone resorption by osteoclasts (antiresorptive effect). The goal of this study was to evaluate: i) anabolic effects of strontium ranelate on the formation of bone-like mineralized matrix in osteoblast cell cultures and ii) changes the drug could cause on the ma...

ba0002p128 | (1) | ICCBH2013

Bone mineral density in survivors of childhood lymphoma

Latoch Eryk , Muszynska-Roslan Katarzyna , Kaminski Marcin Jakub , Panasiuk Anna , Konstantynowicz Jerzy , Krawczuk-Rybak Maryna

Objective: Assessment of bone mineral density in children completing therapy for lymphoma.Methods: Thirty-five children treated for childhood Hodgkin and non-Hodgkin lymphoma at the Department of Pediatric Hematology and Oncology of Medical University of Bialystok in Poland were included. Patients were scanned with DXA at two time points: 1st – up to 5 years and 2nd – above 5 years after the completion of the treatment. Bone mineral density (to...

ba0002p136 | (1) | ICCBH2013

Time to low bone mass occurrence in children diagnosed with acute lymphoblastic leukemia

Latoch Eryk , Muszynska-Roslan Katarzyna , Panasiuk Anna , Kaminski Marcin Jakub , Konstantynowicz Jerzy , Krawczuk-Rybak Maryna

Objective: Assessment of low bone mass in children with acute lymphoblastic leukemia.Methods: A total of 141 patients (83 boys and 57 girls) treated for acute lymphoblastic leukemia at the Department of Pediatric Hematology and Oncology of Medical University of Bialystok in Poland were assessed for low bone mineral density. Depending on age of diagnosis three clinical groups were analyzed: i) up to 5 years old, ii) from 6 to 12 years old, and iii) from 1...

ba0004p91 | (1) | ICCBH2015

Changes in the concentration of vitamin D in the course of intensive treatment of acute lymphoblastic leukemia. A preliminary data

Muszynska-Roslan Katarzyna , Latoch Eryk , Panasiuk Anna , Sawicka-Zukowska Malgorzata , Krawczuk-Rybak Maryna

Objectives: Children during the intensive treatment of cancer might be exposed to vitamin D deficiency and consequently leads to, among other things, bone deficits and low bone mass. The aim of this study was: i) to assess the serum concentration of 25-hydroxyvitamin D (25-OH-D) in children diagnosed with acute lymphoblastic leukemia (ALL) at two time points (time of diagnosis and just after induction treatment), ii) to evaluate the impact of used drugs on the changes of 25-OH...